Literature DB >> 8973177

A pH-dependent conformational change in the B-subunit pentamer of Escherichia coli heat-labile enterotoxin: structural basis and possible functional role for a conserved feature of the AB5 toxin family.

L W Ruddock1, H M Webb, S P Ruston, C Cheesman, R B Freedman, T R Hirst.   

Abstract

The non-covalently associated B-subunit moieties of AB5 toxins, such as cholera toxin and related diarrheagenic enterotoxins, exhibit exceptional pH stability and remain pentameric at pH values as low as 2.0. Here, we investigate the structural basis of a pH-dependent conformational change which occurs within the B5 structure of Escherichia coli heat-labile enterotoxin (EtxB) at around pH 5.0. The use of far-UV CD and fluorescence spectroscopy showed that EtxB pentamers undergo a fully reversible pH-dependent conformational change with a pKa of 4.9 +/- 0.1 (R2 = 0.999) or 5.13 +/- 0.01 (R2 = 0.999), respectively. This renders the pentamer susceptible to SDS-mediated disassembly and decreases its thermal stability by 18 degrees C. A comparison of the pH-dependence of the structural change in EtxB5, with that of a mutant containing a Ser substitution at His 57, revealed that the pKa of the conformational change was shifted from ca. 5.1 to 4.4. This finding suggests that protonation of the imidazole side chain of His 57 might facilitate disruption of a spatially adjacent salt bridge, located between Glu 51 and Lys 91 in each B-subunit, thus triggering the conformational change in the pentameric structure. The pH-dependent conformational change was found to be inhibited when B-subunits bound to monosialoganglioside, GMI; and to have no effect on the stability of interaction between A- and B-subunits within the AB5 complex. This suggests that the conformational change is unlikely to have a direct involvement in toxicity. Conservation of the pH-dependent conformational change in the AB5 toxin family, combined with the potential exposure of the hydrophobic core of beta-barrel in the monomeric units, leads to the proposal that the conformational change may be the common feature that ensures the secretion of these proteins from the Vibrionaceae.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8973177     DOI: 10.1021/bi961865l

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  6 in total

1.  Lack of lacto/neolacto-glycolipids enhances the formation of glycolipid-enriched microdomains, facilitating B cell activation.

Authors:  Akira Togayachi; Yuko Kozono; Yuzuru Ikehara; Hiromi Ito; Nami Suzuki; Yuki Tsunoda; Sumie Abe; Takashi Sato; Kyoko Nakamura; Minoru Suzuki; Hatsumi M Goda; Makoto Ito; Takashi Kudo; Satoru Takahashi; Hisashi Narimatsu
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-14       Impact factor: 11.205

Review 2.  Heat-labile enterotoxin: beyond G(m1) binding.

Authors:  Benjamin Mudrak; Meta J Kuehn
Journal:  Toxins (Basel)       Date:  2010-06-14       Impact factor: 4.546

3.  Cholera toxin B subunits assemble into pentamers--proposition of a fly-casting mechanism.

Authors:  Jihad Zrimi; Alicia Ng Ling; Ernawati Giri-Rachman Arifin; Giovanni Feverati; Claire Lesieur
Journal:  PLoS One       Date:  2010-12-21       Impact factor: 3.240

4.  Variants of Escherichia coli Subtilase Cytotoxin Subunits Show Differences in Complex Formation In Vitro.

Authors:  Maike Krause; Katharina Sessler; Anna Kaziales; Richard Grahl; Sabrina Noettger; Holger Barth; Herbert Schmidt
Journal:  Toxins (Basel)       Date:  2019-12-03       Impact factor: 4.546

5.  Mutational analysis of ganglioside GM(1)-binding ability, pentamer formation, and epitopes of cholera toxin B (CTB) subunits and CTB/heat-labile enterotoxin B subunit chimeras.

Authors:  Michael G Jobling; Randall K Holmes
Journal:  Infect Immun       Date:  2002-03       Impact factor: 3.441

6.  Mutant Escherichia coli heat-labile toxin B subunit that separates toxoid-mediated signaling and immunomodulatory action from trafficking and delivery functions.

Authors:  Sylvia A Fraser; Lolke de Haan; Arron R Hearn; Heather K Bone; Robert J Salmond; A Jennifer Rivett; Neil A Williams; Timothy R Hirst
Journal:  Infect Immun       Date:  2003-03       Impact factor: 3.441

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.